LSE · Stocky rates: Avoid

IMAGING BIOMETRICS LIMITED ORD (IBAI.L)

p0.98 ▼ -2.50% as of 6 Oct, 10:50

Stocky turns companies like IMAGING BIOMETRICS LIMITED ORD into a fun, safe way to learn investing — a virtual portfolio, live scores & charts, and real analyst data, with no real money.

Try Stocky free →
27
/ 100
Avoid

What Stocky thinks

Stocky rates IMAGING BIOMETRICS LIMITED ORD at 27/100 based on business quality, leadership alignment, valuation.

Compounder Score
12/100
Business quality — profitability, growth, capital efficiency.
Moat Score
32/100
Competitive advantage — pricing power, switching costs, network effects.
Resilience
100/100
Downside resilience — customer concentration, supply chain, refinancing risk.
Value Score
12/100
Valuation vs peers and history — is this a good price to pay?
C
Fragile — its debt or losses could cause real trouble.

How safely IMAGING BIOMETRICS LIMITED ORD is financed, graded A++ (strongest) to C from the last five years of accounts: debt against earnings, interest cover, cash against debt, how high and steady profit margins are, return on capital, and whether it generated cash every year. Not part of the Stocky score.

What Stocky gives investors that other tools don't

Every stock is scored across six dimensions built to answer one question — can this business keep compounding? — without a Bloomberg subscription. Here's the actual snapshot for IMAGING BIOMETRICS LIMITED ORD :

27
VERDICT

Stocky Verdict — one score, everything

Quality + moat + leadership + valuation fused into a single 0–100 number. When you see 27/100, you know instantly whether to dig deeper or skip.

Limited
MOAT

Moat Score — is there a real edge?

Pricing power, switching costs, network effects, and 10-year ROIC data. Same framework Morningstar charges for — free inside Stocky.

—
LEADER

Leadership Alignment — is management on your side?

Founder tenure, insider ownership, CEO pay reasonableness, long-term value creation. Six factors, one score — turns "trust the CEO" into evidence.

100
RESILIENCE

Resilience Profile — what could break?

Customer concentration, supply chain, refinancing walls, regulatory exposure. Stocky maps knowable fragilities so you're never blindsided.

Elite
TRACK

Track Record — does the system work?

We don't claim a backtest. The top-scoring basket is recorded every month and measured against the S&P 500 from that date onward — judged on what it said before the outcome was known. The record is young, and published as it stands.

24/7
ALERTS

Alerts + Portfolio insights

Analyst target shifts, insider buys, big moves — plus a monthly Portfolio Health Report telling you what's actually driving your returns.

IMAGING BIOMETRICS LIMITED ORD (IBAI.L) — frequently asked

Is IMAGING BIOMETRICS LIMITED ORD (IBAI.L) a good investment right now?

Stocky rates IMAGING BIOMETRICS LIMITED ORD (IBAI.L) at 27/100 — an Avoid — fundamentals or risks are too weak. The score fuses business quality, moat width, leadership alignment, valuation into a single number.

What is IBAI.L's Stocky Verdict?

IBAI.L's current Stocky Verdict is 27/100, placing it in the "Avoid" band. This composite combines a 12/100 Compounder score, Leadership, 32/100 Moat rating.

Does IMAGING BIOMETRICS LIMITED ORD have a competitive moat?

IMAGING BIOMETRICS LIMITED ORD rates Limited moat (32/100 Moat Score) — based on 10-year return-on-invested-capital, pricing power, switching costs and network effects. Wide moats compound; Limited moats erode.

Is IMAGING BIOMETRICS LIMITED ORD 's leadership aligned with shareholders?

Leadership Alignment for IMAGING BIOMETRICS LIMITED ORD is under analysis. Stocky scores founder tenure, insider ownership, CEO compensation multiple-of-salary, and long-term shareholder value creation.

What are the biggest risks to IBAI.L?

IMAGING BIOMETRICS LIMITED ORD 's Resilience Profile scores 100/100 (higher = more resilient). The profile flags customer concentration, supply chain, refinancing walls and regulatory risks specific to IMAGING BIOMETRICS LIMITED ORD .

This is just the surface. See the whole picture on IMAGING BIOMETRICS LIMITED ORD .

Sign up free and unlock the full analysis on IBAI.L — the same tools professional analysts use, personalised to your portfolio:

  • Every analyst covering IBAI.L — full list with star ratings, price targets, historical hit-rate. Not just the top 3 you see above.
  • Full Resilience Profile — customer concentration, refinancing walls, stress-test scenarios (-20% revenue, +200bp rates) modelled specifically for IBAI.L.
  • Bull & bear thesis — the AI-written counter-argument every retail investor forgets to read.
  • Portfolio fit check — how IBAI.L changes your sector concentration, correlation and Verdict-weighted quality.
  • Ask Stocky AI — "What are the biggest 3-year risks to IBAI.L?" · "Is IBAI.L overvalued vs its 5-year median?" · unlimited follow-ups on your portfolio.
  • Live alerts — analyst target changes, insider buys, big moves — the day they happen.
Start free · 14 days Plus, no card →

Free forever tier includes 5 Verdict lookups a day. Plus €19/mo unlocks everything above. Cancel any time.

STOCKY VERDICT
27
/ 100 · Avoid

See IMAGING BIOMETRICS LIMITED ORD the Stocky way

This page is just a preview. Open the live, interactive version for the full picture:

Stocky Verdict
A plain-English Buy / Hold / Sell score out of 100.
Compounder & Value scores
How strong the business is — and whether it looks cheap.
Interactive charts
1M to 5Y price history with company events plotted on it.
Top analyst targets
What the best-rated Wall Street analysts expect next.
What if? simulator
See what an investment in IBAI.L would be worth today.
Practice portfolio
Buy IBAI.L with virtual money and track it — zero risk.
Free · no real money · learn by doing Open IBAI.L in Stocky →

Or jump straight to the interactive dashboard for IBAI.L in the app.